These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 27518663)

  • 1. Pragmatic Trials.
    Ford I; Norrie J
    N Engl J Med; 2016 Aug; 375(5):454-63. PubMed ID: 27518663
    [No Abstract]   [Full Text] [Related]  

  • 2. Leveraging electronic health record data for pragmatic randomized trials.
    Roe MT
    Clin Trials; 2020 Aug; 17(4):368-369. PubMed ID: 32668979
    [No Abstract]   [Full Text] [Related]  

  • 3. Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.
    Koehler M; Donnelly ET; Kalanovic D; Dagher R; Rothenberg ML
    Ann Oncol; 2016 Jul; 27(7):1342-8. PubMed ID: 27029709
    [No Abstract]   [Full Text] [Related]  

  • 4. Pros and cons of pragmatic clinical trials.
    Lurie JD; Morgan TS
    J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What we talk about when we talk about randomized controlled trials.
    Chetta A; Olivieri D
    Respiration; 2014; 87(1):9-10. PubMed ID: 24281333
    [No Abstract]   [Full Text] [Related]  

  • 6. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
    Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
    J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache: Cluster headache treatment - RCTs versus real-world evidence.
    Martelletti P; Curto M
    Nat Rev Neurol; 2016 Oct; 12(10):557-8. PubMed ID: 27615424
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.
    Bibby AC; Torgerson DJ; Leach S; Lewis-White H; Maskell NA
    Trials; 2018 Jan; 19(1):18. PubMed ID: 29310706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Pragmatism in Recently Published Randomized Clinical Trials.
    Janiaud P; Dal-Ré R; Ioannidis JPA
    JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial.
    Hartman L; Bos R; Buttgereit F; Güler-Yuksel M; Ionescu R; Kok MR; Lems WF; Micaelo M; Opris-Belinski D; Pusztai A; Santos E; Da Silva J; Szekanecz Z; Zeiner K; Zhang D; Boers M
    Scand J Rheumatol; 2019 Jul; 48(4):340-341. PubMed ID: 31132016
    [No Abstract]   [Full Text] [Related]  

  • 11. Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.
    Eichler HG; Koenig F; Arlett P; Enzmann H; Humphreys A; Pétavy F; Schwarzer-Daum B; Sepodes B; Vamvakas S; Rasi G
    Clin Pharmacol Ther; 2020 Apr; 107(4):773-779. PubMed ID: 31574163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pragmatic study designs for older adults with cancer: Report from the U13 conference.
    Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV
    J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explanatory trials versus pragmatic trials.
    Sedgwick P
    BMJ; 2014 Nov; 349():g6694. PubMed ID: 25395503
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trials.
    Blencowe NS; Boddy AP; Harris A; Hanna T; Whiting P; Cook JA; Blazeby JM
    Br J Surg; 2015 Aug; 102(9):1037-47. PubMed ID: 26041565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Giulio Formoso, per l'Associazione Alessandro Liberati - Network italiano Cochrane
    Recenti Prog Med; 2019 Nov; 110(11):524-525. PubMed ID: 31808432
    [No Abstract]   [Full Text] [Related]  

  • 16. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's Important: Patient Engagement in Research.
    Hale D; Marvel D; Wells J;
    J Bone Joint Surg Am; 2020 Oct; 102(20):1836-1838. PubMed ID: 33086354
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.
    Anstrom KJ; Noth I; Flaherty KR; Edwards RH; Albright J; Baucom A; Brooks M; Clark AB; Clausen ES; Durheim MT; Kim DY; Kirchner J; Oldham JM; Snyder LD; Wilson AM; Wisniewski SR; Yow E; Martinez FJ;
    Respir Res; 2020 Mar; 21(1):68. PubMed ID: 32164673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials.
    Murray EJ; Caniglia EC; Swanson SA; Hernández-Díaz S; Hernán MA
    J Clin Epidemiol; 2018 Nov; 103():10-21. PubMed ID: 29966732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials.
    Donovan JL; Paramasivan S; de Salis I; Toerien M
    Trials; 2014 Jan; 15():5. PubMed ID: 24393291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.